ReviewJournal of clinical medicine2018

Novel Indications for Bruton's Tyrosine Kinase Inhibitors, beyond Hematological Malignancies.

Robert Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.